tradingkey.logo
tradingkey.logo
Search

CERo Therapeutics jumps on US FDA's 'fast track' tag for cancer therapy

ReutersSep 5, 2025 12:16 PM
facebooktwitterlinkedin

Shares of drug developer CERo Therapeutics CERO.O rise 11% to $7.65 premarket

Co says its experimental blood cancer therapy, CER-1236, received U.S. FDA's "fast track" tag

FDA's "fast track" tag aims to speed development and review of drugs for serious conditions with unmet medical need

The therapy is being tested in an early stage trial for patients with aggressive forms of acute myeloid leukemia, a type of blood and bone marrow cancer

Stock down 94% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI